Small cell lung cancertreatmentradiationchemotherapySmall-cell lung cancer (SCLC) accounts for 13-20#x0025; of all lung cancers. Stongly associated with smoking and initially responsive to treatment, it results in death within 2-4 months without treatment. Limited-stage disease is treated with ...
1. Fru€h, M., De Ruysscher, D., Popat, S., Crino` , L., Peters, S., and Felip, E.; ESMO Guidelines Working Group (2013). Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and fo...
Rossi A,Maione P,Colantuoni G,et al.Treat ment of small cell lung cancer in the elderly. The Oncologist . 2005Rossi A, Maione P, Colantuoni G, Guerriero C, Ferrara C, Del Gaizo F, et al. Treatment of small cell lung cancer in the elderly. Oncologist 2005;10:399-411.Rossi A, ...
The AJMC® Lung Cancer compendium is a comprehensive resource for clinical news and expert insights for the condition.
small cell lung cancer; treatment Abstract: Lung cancer was relatively uncommon at the turn of the 20th century, and has increased in prevalence at alarming rates, particularly because of the augmented trend in smoking, so that it is now the most common cause of cancer death in the world. ...
Chemotherapy is the most effective treatment for small-cell lung cancer. Doctors may combine radiation therapy with chemotherapy for some patients. Small-cell lung cancer differs from non-small-cell lung cancer in the following ways: Small-cell lung cancer grows rapidly. The time from the developme...
Small-Cell Lung Cancer Treatment Some of the most commonly used combinations of medications used for SCLC are carboplatin (Paraplatin), cisplatin(Platinol- AQ), cyclophosphamide (Cytoxan), docetaxel (Taxotere), doxorubicin (Adriamycin,Rubex), etoposide (Vepesid),irinotecan(Camptosar), lurbinectedin...
小细胞肺癌(Small cell lung cancer, SCLC)是所有肺癌亚型中恶性程度最高的,以快速生长、早期转移和极差的生存预后为特征,占肺癌总发病率的15%左右。近70% SCLC患者确诊时已出现远处转移,总体五年生存率不足10%。与其它癌症(如非小细...
Navigating treatment combinations in small-cell lung cancer The ETER701 trial demonstrates that a four-drug regimen, involving the addition of anti-angiogenesis therapy to immuno-chemotherapy, improves survival outcomes for extensive-stage small-cell lung cancer — but is more indeed better when it co...
Small cell lung canceris an aggressive form of cancer. Previously, surgery was rarely considered because most patients present at the advanced stages of the disease. New research and the advances in medical imaging has challenged this notion proving that, as part of a multimodal treatment pathway,...